Menu Search
Equities

Healthpeak Properties Inc

HC5:DUS

Healthpeak Properties Inc

Actions
  • Price (EUR)19.20
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-38.24%
  • Beta--
Data delayed at least 15 minutes, as of Mar 27 2023 20:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT). The Company acquires, develops, owns, leases, and manages healthcare real estate across the United States. It owns and develops high-quality real estate in the three private-pay healthcare asset classes of life science, medical office, and continuing care retirement communities (CCRCs). The Company operates through two segments: Life science, and Medical office. The Company's Life Science segment properties contain laboratory and office space, which are leased primarily to biotechnology, medical device, and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Company's Medical Office segment includes medical office buildings (MOBs) and hospitals. MOBs typically contain physicians’ offices and examination rooms, and may also include pharmacies, hospital ancillary service space, and outpatient services.

  • Revenue in USD (TTM)2.06bn
  • Net income in USD494.91m
  • Incorporated2022
  • Employees199.00
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.